New drug tested for Tough-to-Treat autoimmune conditions
Disease control
Not yet recruiting
This early-stage study is testing the safety and side effects of an experimental drug called OM336 in people with active Sjogren's disease or inflammatory muscle disease. The trial will enroll 39 adults whose conditions haven't responded well to at least two previous treatments. …
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC